Elevance Health (ELV) Price to FCF (2010 - 2026)

Elevance Health (ELV) has reported Price to FCF for 17 consecutive years, with 51.57 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to FCF rose 5.39% year-over-year to 51.57 in Q2 2026; TTM through Jun 2026 was 13.33, a 18.62% decrease from a year earlier, with the FY2025 full-year figure at 24.38, up 32.23% from the prior year.
• Price to FCF was 51.57 for Q2 2026 at Elevance Health, up from 15.53 in the prior quarter.
• Over five years, Price to FCF peaked at 1013.37 in Q2 2024 and troughed at 370.21 in Q4 2025.
• A 5-year average of 81.58 and a median of 51.5 in 2024 frame the typical range for Price to FCF.
• Across the five-year window, Price to FCF surged 1447.27% in 2024 and sank 269.41% in 2025, its largest moves.
• Over 5 years, Price to FCF stood at 67.22 in 2022, then soared by 50.41% to 33.34 in 2023, then surged by 755.56% to 218.53 in 2024, then tumbled by 269.41% to 370.21 in 2025, then surged by 113.93% to 51.57 in 2026.
• The last three Price to FCF figures came in at 51.57 (Q2 2026), 15.53 (Q1 2026), and 370.21 (Q4 2025), per Business Quant data.